Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Eli Lilly (LLY) has been drawing investor attention after a ...

Eli Lilly (LLY) faces a downgrade to Reduce from HSBC analyst Rajesh Kumar, who cut his price target from $1,070 to $850, citing overestimated obesity drug market size ($80B-$120B by 2032 versus ...

Plug Power reported fourth-quarter 2025 financial results after the market closed today. The company beat top and bottom-line expectations. As of 4:32 p.m. ET, shares of the fuel cell and hydrogen ...

・The analyst now thinks that expectations for obesity drugs’ total addressable market are elevated at over $150 billion. ・While the oral obesity pill launch might expand access to anti-obesity ...

Is LLY a good stock to buy? We came across a bullish thesis on Eli Lilly and Company on Investomine’s Substack. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company's ...

Eli Lilly's stock has skyrocketed in value due to the success of its popular GLP-1 products. Analysts project upside of around 17% for the stock in the near term. The healthcare stock's high valuation ...

John Carlsen has more than a decade of experience testing and reviewing home tech products, with a major focus on smart home security. He earned his BS in journalism from Utah Valley University. In ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Get the latest news on Eli Lilly stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Eli Lilly performance ...

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products ...